Related Experiment Video
Updated: Jan 21, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Stent Angioplasty in Acute-Phase ICAD-LVO: A Retrospective Cohort Study on Long-Term Recurrence and Safety Outcomes
Lin Chen1, Shuai Mi1, Yuxuan He1
1Department of Neurology, The First Affiliated Hospital (Southwest Hospital), Army Medical University, Chongqing, China.
Insights
Emergency stent angioplasty for intracranial atherosclerotic disease-related large vessel occlusion (ICAD-LVO) significantly reduces long-term stroke recurrence. This treatment was not linked to increased procedural complications, offering a safer approach for ICAD-LVO patients.
Area of Science:
- Neurology
- Vascular Surgery
- Interventional Neuroradiology
Background:
- Intracranial atherosclerotic disease-related large vessel occlusion (ICAD-LVO) poses a significant stroke risk.
- Current treatment strategies lack long-term outcome data, focusing primarily on 90-day recovery.
- The persistent risk of recurrent stroke necessitates evaluating advanced therapeutic interventions.
Purpose of the Study:
- To investigate the efficacy of stent angioplasty in reducing long-term stroke recurrence in ICAD-LVO patients.
- To assess whether stent angioplasty achieves successful vascular recanalization.
- To compare the long-term outcomes of stenting versus non-stenting therapies for ICAD-LVO.
Main Methods:
- A retrospective cohort study included 131 patients with ICAD-LVO.
- Patients were divided into emergency stenting (65) and non-stenting therapy (66) groups.
- Stroke recurrence from 30 days to 1 year was the primary outcome, analyzed using competing risks regression.
Main Results:
- The 1-year cumulative incidence of stroke recurrence was lower in the stent group (4.9%) compared to the non-stent group (13.7%).
- Stenting was significantly associated with a reduced risk of recurrence (sHR 0.19, P=0.026) after adjustment.
- No increased risk of symptomatic intracranial hemorrhage, parenchymal hematoma type 2, or 90-day mortality was observed with stenting.
Conclusions:
- Emergency stent angioplasty is associated with a lower risk of 30-day to 1-year stroke recurrence in ICAD-LVO.
- Stent angioplasty did not increase the risk of procedural complications in this cohort.
- These findings suggest stenting as a potentially effective strategy for managing ICAD-LVO and preventing recurrent strokes.
Objective:
The optimal treatment strategy of Intracranial atherosclerotic disease-related large vessel occlusion (ICAD-LVO) remains undetermined. Current evaluation criteria focus on 90-day functional independence for acute-phase management, yet this timeframe does not represent the therapeutic endpoint given the persistent risk of recurrent stroke in this patient population. This study aims to examine whether stent angioplasty in patients with ICAD-LVO reduces long-term stroke recurrence risk while achieving successful vascular recanalization.
Methods:
In this retrospective cohort study of 131 ICAD-LVO patients (June 2022-January 2024), 65 underwent emergency stenting and 66 received nonstenting therapy. The primary outcome was 30-day to 1-year stroke recurrence, analyzed using competing risks regression (Fine-Gray model). Secondary outcomes included safety and 90-day functional status.
Results:
The 1-year cumulative incidence of recurrence was 4.9% in the stent group versus 13.7% in the nonstent group (Gray's test, P = 0.088). After adjustment, stenting was significantly associated with a lower recurrence risk (subdistribution hazard ratio 0.19, 95% confidence interval 0.04-0.82; P = 0.026). A history of stroke/transient ischemic attack predicted higher risk (subdistribution hazard ratio 8.81, P = 0.002). Stenting was not associated with increased symptomatic intracranial hemorrhage, parenchymal hematoma type 2, 90-day mortality, or differences in 90-day functional independence.
Conclusions:
In this retrospective cohort study, emergency stent angioplasty was associated with a lower risk of 30-day to 1-year stroke recurrence in intracranial atherosclerotic occlusions and was not associated with an increased risk of procedural complications.
More Related Videos
Related Concept Videos
Survey Safety
Phase Transitions
Predicting Reaction Outcomes
Acute Pyelonephritis II: Diagnostic Studies and Management
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...

